APO Research
Talk to an analyst

APO RESEARCH · REPORT

NAD+ Enhancer

Compare research editions
View pricing & licenses

Selected research

Industry Research

NAD+ Enhancer Industry Research Report 2026

27 December 2025125 pages

Choose your research edition.

Industry ResearchNAD+ Enhancer Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NAD+ Enhancer Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NAD+ Enhancer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NAD+ Enhancer Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal NAD+ Enhancer Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global NAD+ Enhancer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for NAD+ Enhancer is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for NAD+ Enhancer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for NAD+ Enhancer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of NAD+ Enhancer include EffePharm, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), GeneHarbor, NOMON Co., Ltd. (Teijin), Maac10 Formulas, Kingdomway, Herbalmax, Genex Formulas and EZZ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global NAD+ Enhancer market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

NAD+ Enhancer Market by Company

EffePharm

Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)

GeneHarbor

NOMON Co., Ltd. (Teijin)

Maac10 Formulas

Kingdomway

Herbalmax

Genex Formulas

EZZ

Elysium Health

Chromadex

CELFULL

Bontac

NAD+ Enhancer Segment by Type

Content ＜98%

Content ≥98%

NAD+ Enhancer Segment by Application

Health Care Products

ClinicsBeauty Products

Others

NAD+ Enhancer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Enhancer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NAD+ Enhancer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Enhancer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of NAD+ Enhancer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of NAD+ Enhancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global NAD+ Enhancer Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global NAD+ Enhancer Sales (K Units) of Manufacturers (2021-2026) Table 7. Global NAD+ Enhancer Sales Market Share by Manufacturers (2021-2026) Table 8. Global NAD+ Enhancer Revenue of Manufacturers (2021-2026) Table 9. Global NAD+ Enhancer Revenue Share by Manufacturers (2021-2026) Table 10. Global Market NAD+ Enhancer Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global NAD+ Enhancer Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of NAD+ Enhancer, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of NAD+ Enhancer, Product Type & Application Table 14. Global NAD+ Enhancer Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global NAD+ Enhancer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. EffePharm Company Information Table 19. EffePharm Business Overview Table 20. EffePharm NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. EffePharm NAD+ Enhancer Product Portfolio Table 22. EffePharm Recent Developments Table 23. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information Table 24. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview Table 25. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio Table 27. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments Table 28. GeneHarbor Company Information Table 29. GeneHarbor Business Overview Table 30. GeneHarbor NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. GeneHarbor NAD+ Enhancer Product Portfolio Table 32. GeneHarbor Recent Developments Table 33. NOMON Co., Ltd. (Teijin) Company Information Table 34. NOMON Co., Ltd. (Teijin) Business Overview Table 35. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio Table 37. NOMON Co., Ltd. (Teijin) Recent Developments Table 38. Maac10 Formulas Company Information Table 39. Maac10 Formulas Business Overview Table 40. Maac10 Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Maac10 Formulas NAD+ Enhancer Product Portfolio Table 42. Maac10 Formulas Recent Developments Table 43. Kingdomway Company Information Table 44. Kingdomway Business Overview Table 45. Kingdomway NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Kingdomway NAD+ Enhancer Product Portfolio Table 47. Kingdomway Recent Developments Table 48. Herbalmax Company Information Table 49. Herbalmax Business Overview Table 50. Herbalmax NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Herbalmax NAD+ Enhancer Product Portfolio Table 52. Herbalmax Recent Developments Table 53. Genex Formulas Company Information Table 54. Genex Formulas Business Overview Table 55. Genex Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Genex Formulas NAD+ Enhancer Product Portfolio Table 57. Genex Formulas Recent Developments Table 58. EZZ Company Information Table 59. EZZ Business Overview Table 60. EZZ NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. EZZ NAD+ Enhancer Product Portfolio Table 62. EZZ Recent Developments Table 63. Elysium Health Company Information Table 64. Elysium Health Business Overview Table 65. Elysium Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Elysium Health NAD+ Enhancer Product Portfolio Table 67. Elysium Health Recent Developments Table 68. Chromadex Company Information Table 69. Chromadex Business Overview Table 70. Chromadex NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Chromadex NAD+ Enhancer Product Portfolio Table 72. Chromadex Recent Developments Table 73. CELFULL Company Information Table 74. CELFULL Business Overview Table 75. CELFULL NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. CELFULL NAD+ Enhancer Product Portfolio Table 77. CELFULL Recent Developments Table 78. Bontac Company Information Table 79. Bontac Business Overview Table 80. Bontac NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bontac NAD+ Enhancer Product Portfolio Table 82. Bontac Recent Developments Table 83. Global NAD+ Enhancer Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global NAD+ Enhancer Sales by Region (2021-2026) & (K Units) Table 85. Global NAD+ Enhancer Sales Market Share by Region (2021-2026) Table 86. Global NAD+ Enhancer Sales by Region (2027-2032) & (K Units) Table 87. Global NAD+ Enhancer Sales Market Share by Region (2027-2032) Table 88. Global NAD+ Enhancer Revenue by Region (2021-2026) & (US$ Million) Table 89. Global NAD+ Enhancer Revenue Market Share by Region (2021-2026) Table 90. Global NAD+ Enhancer Revenue by Region (2027-2032) & (US$ Million) Table 91. Global NAD+ Enhancer Revenue Market Share by Region (2027-2032) Table 92. North America NAD+ Enhancer Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 94. North America NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 95. North America NAD+ Enhancer Revenue by Country (2021-2026) & (US$ Million) Table 96. North America NAD+ Enhancer Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe NAD+ Enhancer Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 99. Europe NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 100. Europe NAD+ Enhancer Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe NAD+ Enhancer Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific NAD+ Enhancer Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific NAD+ Enhancer Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific NAD+ Enhancer Revenue by Country (2027-2032) & (US$ Million) Table 107. South America NAD+ Enhancer Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 109. South America NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 110. South America NAD+ Enhancer Revenue by Country (2021-2026) & (US$ Million) Table 111. South America NAD+ Enhancer Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa NAD+ Enhancer Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa NAD+ Enhancer Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa NAD+ Enhancer Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa NAD+ Enhancer Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa NAD+ Enhancer Revenue by Country (2027-2032) & (US$ Million) Table 117. Global NAD+ Enhancer Sales by Type (2021-2026) & (K Units) Table 118. Global NAD+ Enhancer Sales by Type (2027-2032) & (K Units) Table 119. Global NAD+ Enhancer Sales Market Share by Type (2021-2026) Table 120. Global NAD+ Enhancer Sales Market Share by Type (2027-2032) Table 121. Global NAD+ Enhancer Revenue by Type (2021-2026) & (US$ Million) Table 122. Global NAD+ Enhancer Revenue by Type (2027-2032) & (US$ Million) Table 123. Global NAD+ Enhancer Revenue Market Share by Type (2021-2026) Table 124. Global NAD+ Enhancer Revenue Market Share by Type (2027-2032) Table 125. Global NAD+ Enhancer Price by Type (2021-2026) & (US$/Unit) Table 126. Global NAD+ Enhancer Price by Type (2027-2032) & (US$/Unit) Table 127. Global NAD+ Enhancer Sales by Application (2021-2026) & (K Units) Table 128. Global NAD+ Enhancer Sales by Application (2027-2032) & (K Units) Table 129. Global NAD+ Enhancer Sales Market Share by Application (2021-2026) Table 130. Global NAD+ Enhancer Sales Market Share by Application (2027-2032) Table 131. Global NAD+ Enhancer Revenue by Application (2021-2026) & (US$ Million) Table 132. Global NAD+ Enhancer Revenue by Application (2027-2032) & (US$ Million) Table 133. Global NAD+ Enhancer Revenue Market Share by Application (2021-2026) Table 134. Global NAD+ Enhancer Revenue Market Share by Application (2027-2032) Table 135. Global NAD+ Enhancer Price by Application (2021-2026) & (US$/Unit) Table 136. Global NAD+ Enhancer Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. NAD+ Enhancer Distributors List Table 140. NAD+ Enhancer Customers List Table 141. NAD+ Enhancer Industry Trends Table 142. NAD+ Enhancer Industry Drivers Table 143. NAD+ Enhancer Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. NAD+ Enhancer Product Image Figure 5. Global NAD+ Enhancer Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global NAD+ Enhancer Market Size (2021-2032) & (US$ Million) Figure 7. Global NAD+ Enhancer Sales (2021-2032) & (K Units) Figure 8. Global NAD+ Enhancer Average Price (US$/Unit) & (2021-2032) Figure 9. Content ＜98% Product Image Figure 10. Content ≥98% Product Image Figure 11. Health Care Products Product Image Figure 12. ClinicsBeauty Products Product Image Figure 13. Others Product Image Figure 14. Global NAD+ Enhancer Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of NAD+ Enhancer, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 NAD+ Enhancer Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global NAD+ Enhancer Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global NAD+ Enhancer Sales by Region in 2025 Figure 20. Global NAD+ Enhancer Revenue by Region in 2025 Figure 21. North America NAD+ Enhancer Market Size by Country in 2025 Figure 22. North America NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 23. North America NAD+ Enhancer Revenue Market Share by Country (2021-2032) Figure 24. United States NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe NAD+ Enhancer Market Size by Country in 2025 Figure 28. Europe NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 29. Europe NAD+ Enhancer Revenue Market Share by Country (2021-2032) Figure 30. Germany NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific NAD+ Enhancer Market Size by Country in 2025 Figure 41. Asia Pacific NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific NAD+ Enhancer Revenue Market Share by Country (2021-2032) Figure 43. China NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America NAD+ Enhancer Market Size by Country in 2025 Figure 52. South America NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 53. South America NAD+ Enhancer Revenue Market Share by Country (2021-2032) Figure 54. Brazil NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa NAD+ Enhancer Market Size by Country in 2025 Figure 58. Middle East and Africa NAD+ Enhancer Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa NAD+ Enhancer Revenue Market Share by Country (2021-2032) Figure 60. Egypt NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries NAD+ Enhancer Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global NAD+ Enhancer Sales Market Share by Type (2021-2032) Figure 66. Global NAD+ Enhancer Revenue Market Share by Type (2021-2032) Figure 67. Global NAD+ Enhancer Price (US$/Unit) by Type (2021-2032) Figure 68. Global NAD+ Enhancer Sales Market Share by Application (2021-2032) Figure 69. Global NAD+ Enhancer Revenue Market Share by Application (2021-2032) Figure 70. Global NAD+ Enhancer Price (US$/Unit) by Application (2021-2032) Figure 71. NAD+ Enhancer Value Chain Figure 72. NAD+ Enhancer Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. NAD+ Enhancer Industry Opportunities and Challenges

Scope & coverage.

Types
  • Content ＜98%
  • Content ≥98%
Applications
  • Health Care Products
  • ClinicsBeauty Products
  • Others
Companies covered
  • EffePharm
  • Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  • GeneHarbor
  • NOMON Co., Ltd. (Teijin)
  • Maac10 Formulas
  • Kingdomway
  • Herbalmax
  • Genex Formulas
  • EZZ
  • Elysium Health
  • Chromadex
  • CELFULL
  • Bontac

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global NAD+ Enhancer Market Size (2021-2032)
  4. 2.2.2 Global NAD+ Enhancer Sales (2021-2032)
  5. 2.2.3 Global NAD+ Enhancer Market Average Price (2021-2032)
  6. 2.3 NAD+ Enhancer by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Content ＜98%
  9. 2.3.3 Content ≥98%
  10. 2.4 NAD+ Enhancer by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Health Care Products
  13. 2.4.3 ClinicsBeauty Products
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global NAD+ Enhancer Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global NAD+ Enhancer Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global NAD+ Enhancer Revenue of Manufacturers (2021-2026)
  4. 3.4 Global NAD+ Enhancer Average Price by Manufacturers (2021-2026)
  5. 3.5 Global NAD+ Enhancer Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of NAD+ Enhancer, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of NAD+ Enhancer, Product Type & Application
  8. 3.8 Global Manufacturers of NAD+ Enhancer, Established Date
  9. 3.9 Global NAD+ Enhancer Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 EffePharm
  2. 4.1.1 EffePharm Company Information
  3. 4.1.2 EffePharm Business Overview
  4. 4.1.3 EffePharm NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 EffePharm NAD+ Enhancer Product Portfolio
  6. 4.1.5 EffePharm Recent Developments
  7. 4.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
  8. 4.2.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
  9. 4.2.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
  10. 4.2.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Portfolio
  12. 4.2.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
  13. 4.3 GeneHarbor
  14. 4.3.1 GeneHarbor Company Information
  15. 4.3.2 GeneHarbor Business Overview
  16. 4.3.3 GeneHarbor NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 GeneHarbor NAD+ Enhancer Product Portfolio
  18. 4.3.5 GeneHarbor Recent Developments
  19. 4.4 NOMON Co., Ltd. (Teijin)
  20. 4.4.1 NOMON Co., Ltd. (Teijin) Company Information
  21. 4.4.2 NOMON Co., Ltd. (Teijin) Business Overview
  22. 4.4.3 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Portfolio
  24. 4.4.5 NOMON Co., Ltd. (Teijin) Recent Developments
  25. 4.5 Maac10 Formulas
  26. 4.5.1 Maac10 Formulas Company Information
  27. 4.5.2 Maac10 Formulas Business Overview
  28. 4.5.3 Maac10 Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Maac10 Formulas NAD+ Enhancer Product Portfolio
  30. 4.5.5 Maac10 Formulas Recent Developments
  31. 4.6 Kingdomway
  32. 4.6.1 Kingdomway Company Information
  33. 4.6.2 Kingdomway Business Overview
  34. 4.6.3 Kingdomway NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Kingdomway NAD+ Enhancer Product Portfolio
  36. 4.6.5 Kingdomway Recent Developments
  37. 4.7 Herbalmax
  38. 4.7.1 Herbalmax Company Information
  39. 4.7.2 Herbalmax Business Overview
  40. 4.7.3 Herbalmax NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Herbalmax NAD+ Enhancer Product Portfolio
  42. 4.7.5 Herbalmax Recent Developments
  43. 4.8 Genex Formulas
  44. 4.8.1 Genex Formulas Company Information
  45. 4.8.2 Genex Formulas Business Overview
  46. 4.8.3 Genex Formulas NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Genex Formulas NAD+ Enhancer Product Portfolio
  48. 4.8.5 Genex Formulas Recent Developments
  49. 4.9 EZZ
  50. 4.9.1 EZZ Company Information
  51. 4.9.2 EZZ Business Overview
  52. 4.9.3 EZZ NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 EZZ NAD+ Enhancer Product Portfolio
  54. 4.9.5 EZZ Recent Developments
  55. 4.10 Elysium Health
  56. 4.10.1 Elysium Health Company Information
  57. 4.10.2 Elysium Health Business Overview
  58. 4.10.3 Elysium Health NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Elysium Health NAD+ Enhancer Product Portfolio
  60. 4.10.5 Elysium Health Recent Developments
  61. 4.11 Chromadex
  62. 4.11.1 Chromadex Company Information
  63. 4.11.2 Chromadex Business Overview
  64. 4.11.3 Chromadex NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Chromadex NAD+ Enhancer Product Portfolio
  66. 4.11.5 Chromadex Recent Developments
  67. 4.12 CELFULL
  68. 4.12.1 CELFULL Company Information
  69. 4.12.2 CELFULL Business Overview
  70. 4.12.3 CELFULL NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 CELFULL NAD+ Enhancer Product Portfolio
  72. 4.12.5 CELFULL Recent Developments
  73. 4.13 Bontac
  74. 4.13.1 Bontac Company Information
  75. 4.13.2 Bontac Business Overview
  76. 4.13.3 Bontac NAD+ Enhancer Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Bontac NAD+ Enhancer Product Portfolio
  78. 4.13.5 Bontac Recent Developments
5 Global NAD+ Enhancer Market Scenario by Region
  1. 5.1 Global NAD+ Enhancer Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global NAD+ Enhancer Sales by Region: 2021-2032
  3. 5.2.1 Global NAD+ Enhancer Sales by Region: 2021-2026
  4. 5.2.2 Global NAD+ Enhancer Sales by Region: 2027-2032
  5. 5.3 Global NAD+ Enhancer Revenue by Region: 2021-2032
  6. 5.3.1 Global NAD+ Enhancer Revenue by Region: 2021-2026
  7. 5.3.2 Global NAD+ Enhancer Revenue by Region: 2027-2032
  8. 5.4 North America NAD+ Enhancer Market Facts & Figures by Country
  9. 5.4.1 North America NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America NAD+ Enhancer Sales by Country (2021-2032)
  11. 5.4.3 North America NAD+ Enhancer Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe NAD+ Enhancer Market Facts & Figures by Country
  16. 5.5.1 Europe NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe NAD+ Enhancer Sales by Country (2021-2032)
  18. 5.5.3 Europe NAD+ Enhancer Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific NAD+ Enhancer Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific NAD+ Enhancer Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific NAD+ Enhancer Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America NAD+ Enhancer Market Facts & Figures by Country
  41. 5.7.1 South America NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America NAD+ Enhancer Sales by Country (2021-2032)
  43. 5.7.3 South America NAD+ Enhancer Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa NAD+ Enhancer Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa NAD+ Enhancer Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa NAD+ Enhancer Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa NAD+ Enhancer Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global NAD+ Enhancer Sales by Type (2021-2032)
  2. 6.1.1 Global NAD+ Enhancer Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global NAD+ Enhancer Sales Market Share by Type (2021-2032)
  4. 6.2 Global NAD+ Enhancer Revenue by Type (2021-2032)
  5. 6.2.1 Global NAD+ Enhancer Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global NAD+ Enhancer Revenue Market Share by Type (2021-2032)
  7. 6.3 Global NAD+ Enhancer Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global NAD+ Enhancer Sales by Application (2021-2032)
  2. 7.1.1 Global NAD+ Enhancer Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global NAD+ Enhancer Sales Market Share by Application (2021-2032)
  4. 7.2 Global NAD+ Enhancer Revenue by Application (2021-2032)
  5. 7.2.1 Global NAD+ Enhancer Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global NAD+ Enhancer Revenue Market Share by Application (2021-2032)
  7. 7.3 Global NAD+ Enhancer Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 NAD+ Enhancer Value Chain Analysis
  2. 8.1.1 NAD+ Enhancer Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 NAD+ Enhancer Production Mode & Process
  5. 8.2 NAD+ Enhancer Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 NAD+ Enhancer Distributors
  8. 8.2.3 NAD+ Enhancer Customers
9 Global NAD+ Enhancer Analyzing Market Dynamics
  1. 9.1 NAD+ Enhancer Industry Trends
  2. 9.2 NAD+ Enhancer Industry Drivers
  3. 9.3 NAD+ Enhancer Industry Opportunities and Challenges
  4. 9.4 NAD+ Enhancer Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst